Chaperones in neurodegeneration

Journal of Neuroscience

Volumn 35, Issue 41, 2015, Pages 13853-13859

  Lindberg, Iris ^a   Shorter, James ^b   Wiseman, R Luke ^c   Chiti, Fabrizio ^d   Dickey, Chad A ^e   McLean, Pamela J ^f  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF FLORENCE   (Italy)

^e UNIVERSITY OF SOUTH FLORIDA   (United States)

^f MAYO CLINIC   (United States)

Author keywords

Chaperone; Heat shock proteins; Neurodegeneration; Parkinson s disease; Protein misfolding; Proteostasis

Indexed keywords

AMYLOID BETA PROTEIN; CHAPERONE; CHAPERONE 7B2; CHAPERONE PROSAAS; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 104; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 40; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; HEAT SHOCK PROTEIN 90 INHIBITOR; PREALBUMIN; TAU PROTEIN; UNCLASSIFIED DRUG;

CYTOTOXICITY; EXTRACELLULAR SPACE; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; OLIGOMERIZATION; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ENGINEERING; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN HOMEOSTASIS; REVIEW; UNFOLDED PROTEIN RESPONSE; UPREGULATION; ANIMAL; DEGENERATIVE DISEASE; GENETICS; METABOLISM;

ANIMALS; HUMANS; MOLECULAR CHAPERONES; NEURODEGENERATIVE DISEASES;

EID: 84944561352     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.2600-15.2015     Document Type: Review

References (102)

1. Abdi F, Quinn JF, Jankovic J, McIntosh M, Leverenz JB, Peskind E, Nixon R, Nutt J, Chung K, Zabetian C, Samii A, Lin M, Hattan S, Pan C, Wang Y, Jin J, Zhu D, Li GJ, Liu Y, Waichunas D, et al. (2006) Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders. J Alzheimers Dis 9:293-348. Medline
2. Alexopoulos JA, Guarné A, Ortega J (2012) ClpP: a structurally dynamic protease regulated by AAAβ proteins. J Struct Biol 179:202-210. CrossRef Medline
3. Auluck PK, Chan HY, Trojanowski JQ, Lee VM, Bonini NM (2002) Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson’s disease. Science 295:865-868. CrossRef Medline
4. Bayés A, Grant SG (2009) Neuroproteomics: understanding the molecular organization and complexity of the brain. Nat Rev Neurosci 10:635-646. CrossRef Medline
5. Binger KJ, Ecroyd H, Yang S, Carver JA, Howlett GJ, Griffin MD (2013) Avoiding the oligomeric state: 'B-crystallin inhibits fragmentation and induces dissociation of apolipoprotein C-II amyloid fibrils. FASEB J 27: 1214-1222. CrossRef Medline
6. Blair LJ, Nordhues BA, Hill SE, Scaglione KM, O’Leary JC 3rd, Fontaine SN, Breydo L, Zhang B, Li P, Wang L, Cotman C, Paulson HL, Muschol M, Uversky VN, Klengel T, Binder EB, Kayed R, Golde TE, Berchtold N, Dickey CA (2013) Accelerated neurodegeneration through chaperonemediated oligomerization of tau. J Clin Invest 123:4158-4169. CrossRef Medline
7. Blancas-Mejía LM, Ramirez-Alvarado M (2013) Systemic amyloidoses. Annu Rev Biochem 82:745-774. CrossRef Medline
8. Buxbaum JN, Ye Z, Reixach N, Friske L, Levy C, Das P, Golde T, Masliah E, Roberts AR, Bartfai T (2008) Transthyretin protects Alzheimer’s mice from the behavioral and biochemical effects of Abeta toxicity. Proc Natl Acad Sci U S A 105:2681-2686. CrossRef Medline
9. Carman A, Kishinevsky S, Koren J, Lou W, Chiosis G (2013) Chaperonedependent neurodegeneration: a molecular perspective on therapeutic intervention. J Alzheimers Dis Parkinsonism 2013[Suppl 10]:pii007.
10. Cascella R, Conti S, Mannini B, Li X, Buxbaum JN, Tiribilli B, Chiti F, Cecchi C (2013) Transthyretin suppresses the toxicity of oligomers formed by misfolded proteins in vitro. Biochim Biophys Acta 1832:2302-2314. CrossRef Medline
11. Cashikar AG, Duennwald M, Lindquist SL (2005) A chaperone pathway in protein disaggregation. Hsp26 alters the nature of protein aggregates to facilitate reactivation by Hsp104. J Biol Chem 280:23869-23875. CrossRef Medline
12. Chaudhuri B, Stephan C, Huijbregts RP, Martens GJ (1995) The neuroendocrine protein 7B2 acts as a molecular chaperone in the in vitro folding of human insulin-like growth factor-1 secreted from yeast. Biochem Biophys Res Commun 211:417-425. CrossRef Medline
13. Choi SH, Leight SN, Lee VM, Li T, Wong PC, Johnson JA, Saraiva MJ, Sisodia SS (2007) Accelerated Abeta deposition in APPswe/PS1-E9 mice with hemizygous deletions of TTR (transthyretin). J Neurosci 27:7006-7010. CrossRef Medline
14. Choi YS, Hou S, Choe LH, Lee KH (2013) Targeted human cerebrospinal fluid proteomics for the validation of multiple Alzheimer’s disease biomarker candidates. J Chromatogr B Analyt Technol Biomed Life Sci 930: 129-135. CrossRef Medline
15. Cooley CB, Ryno LM, Plate L, Morgan GJ, Hulleman JD, Kelly JW, Wiseman RL (2014) Unfolded protein response activation reduces secretion and extracellular aggregation of amyloidogenic immunoglobulin light chain. Proc Natl Acad Sci U S A 111:13046-13051. CrossRef Medline
16. Couthouis J, Hart MP, Erion R, King OD, Diaz Z, Nakaya T, Ibrahim F, Kim HJ, Mojsilovic-Petrovic J, Panossian S, Kim CE, Frackelton EC, Solski JA, Williams KL, Clay-Falcone D, Elman L, McCluskey L, Greene R, Hakonarson H, Kalb RG, et al. (2012) Evaluating the role of the FUS/TLSrelated gene EWSR1 in amyotrophic lateral sclerosis. Hum Mol Genet 21:2899-2911. CrossRef Medline
17. Cushman M, Johnson BS, King OD, Gitler AD, Shorter J (2010) Prion-like disorders: blurring the divide between transmissibility and infectivity. J Cell Sci 123:1191-1201. CrossRef Medline
18. Danzer KM, Ruf WP, Putcha P, Joyner D, Hashimoto T, Glabe C, Hyman BT, McLean PJ (2011) Heat-shock protein 70 modulates toxic extracellular '-synuclein oligomers and rescues trans-synaptic toxicity. FASEB J 25: 326-336. CrossRef Medline
19. Dasgupta I, Sanglas L, Enghild JJ, Lindberg I (2012) The neuroendocrine protein 7B2 is intrinsically disordered. Biochemistry 51:7456-7464. CrossRef Medline
20. Davidsson P, Sjögren M, Andreasen N, Lindbjer M, Nilsson CL, Westman-Brinkmalm A, Blennow K (2002) Studies of the pathophysiological mechanisms in frontotemporal dementia by proteome analysis of CSF proteins. Brain Res Mol Brain Res 109:128-133. CrossRef Medline
21. DeSantis ME, Leung EH, Sweeny EA, Jackrel ME, Cushman-Nick M, Neuhaus-Follini A, Vashist S, Sochor MA, Knight MN, Shorter J (2012) Operational plasticity enables hsp104 to disaggregate diverse amyloid and nonamyloid clients. Cell 151:778-793. CrossRef Medline
22. Deture M, Hicks C, Petrucelli L (2010) Targeting heat shock proteins in tauopathies. Curr Alzheimer Res 7:677-684. CrossRef Medline
23. Dickey CA, Yue M, Lin WL, Dickson DW, Dunmore JH, Lee WC, Zehr C, West G, Cao S, Clark AM, Caldwell GA, Caldwell KA, Eckman C, Patterson C, Hutton M, Petrucelli L (2006) Deletion of the ubiquitin ligase CHIP leads to the accumulation, but not the aggregation, of both endogenous phospho-and caspase-3-cleaved tau species. J Neurosci 26:6985-6996. CrossRef Medline
24. Doyle SM, Genest O, Wickner S (2013) Protein rescue from aggregates by powerful molecular chaperone machines. Nat Rev Mol Cell Biol 14:617-629. CrossRef Medline
25. Ebrahimi-Fakhari D, Cantuti-Castelvetri I, Fan Z, Rockenstein E, Masliah E, Hyman BT, McLean PJ, Unni VK (2011) Distinct roles in vivo for the ubiquitin-proteasome system and the autophagy-lysosomal pathway in the degradation of '-synuclein. J Neurosci 31:14508-14520. CrossRef Medline
26. Eisenberg D, Jucker M (2012) The amyloid state of proteins in human diseases. Cell 148:1188-1203. CrossRef Medline
27. Feng Y, Reznik SE, Fricker LD (2002) ProSAAS and prohormone convertase 1 are broadly expressed during mouse development. Brain Res Gene Expr Patterns 1:135-140. CrossRef Medline
28. Finehout EJ, Franck Z, Choe LH, Relkin N, Lee KH (2007) Cerebrospinal fluid proteomic biomarkers for Alzheimer’s disease. Ann Neurol 61: 120-129. CrossRef Medline
29. Fricker LD, McKinzie AA, Sun J, Curran E, Qian Y, Yan L, Patterson SD, Courchesne PL, Richards B, Levin N, Mzhavia N, Devi LA, Douglass J (2000) Identification and characterization of proSAAS, a granin-like neuroendocrine peptide precursor that inhibits prohormone processing. J Neurosci 20:639-648. Medline
30. Fujikake N, Nagai Y, Popiel HA, Okamoto Y, Yamaguchi M, Toda T (2008) Heat shock transcription factor 1-activating compounds suppress polyglutamineinduced neurodegeneration through induction of multiple molecular chaperones. J Biol Chem 283:26188-26197. CrossRef Medline
31. Genereux JC, Qu S, Zhou M, Ryno LM, Wang S, Shoulders MD, Kaufman RJ, Lasmézas CI, Kelly JW, Wiseman RL (2015) Unfolded protein responseinduced ERdj3 secretion links ER stress to extracellular proteostasis. EMBO J 34:4-19. CrossRef Medline
32. Glover JR, Lindquist S (1998) Hsp104, Hsp70, and Hsp40: a novel chaperone system that rescues previously aggregated proteins. Cell 94:73-82. CrossRef Medline
33. Goedert M, Wischik CM, Crowther RA, Walker JE, Klug A (1988) Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubuleassociated protein tau. Proc Natl Acad Sci U S A 85:4051-4055. CrossRef Medline
34. Hall GF, Patuto BA (2012) Is tau ready for admission to the prion club? Prion 6:223-233. CrossRef Medline
35. Hartl FU, Bracher A, Hayer-Hartl M (2011) Molecular chaperones in protein folding and proteostasis. Nature 475:324-332. CrossRef Medline
36. Helwig M, Hoshino A, Berridge C, Lee SN, Lorenzen N, Otzen DE, Eriksen JL, Lindberg I (2013) The neuroendocrine protein 7B2 suppresses the aggregation of neurodegenerative disease-related proteins. J Biol Chem 288: 1114-1124. CrossRef Medline
37. Hetz C, Mollereau B (2014) Disturbance of endoplasmic reticulum proteostasis in neurodegenerative diseases. Nat Rev Neurosci 15:233-249. CrossRef Medline
38. Hilton GR, Lioe H, Stengel F, Baldwin AJ, Benesch JL (2013) Small heatshock proteins: paramedics of the cell. Top Curr Chem 328:69-98. CrossRef Medline
39. Hodson S, Marshall JJ, Burston SG (2012) Mappingthe road to recovery: the ClpB/Hsp104 molecular chaperone. J Struct Biol 179:161-171. CrossRef Medline
40. Hoshino A, Helwig M, Rezaei S, Berridge C, Eriksen JL, Lindberg I (2014) A novel function for proSAAS as an amyloid anti-aggregant in Alzheimer’s disease. J Neurochem 128:419-430. CrossRef Medline
41. Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H, Pickering-Brown S, Chakraverty S, Isaacs A, Grover A, Hackett J, Adamson J, Lincoln S, Dickson D, Davies P, Petersen RC, Stevens M, de Graaff E, Wauters E, van Baren J, et al. (1998) Association of missense and 5’-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393:702-705. CrossRef Medline
42. Iguchi H, Chan JS, Seidah NG, Chrétien M (1984) Tissue distribution and molecular forms of a novel pituitary protein in the rat. Neuroendocrinology 39:453-458. CrossRef Medline
43. Jackrel ME, Shorter J (2014) Potentiated Hsp104 variants suppress toxicity of diverse neurodegenerative disease-linked proteins. Dis Model Mech 7:1175-1184. CrossRef Medline
44. Jackrel ME, Shorter J (2015) Engineering enhanced protein disaggregases for neurodegenerative disease. Prion 9:90-109. CrossRef Medline
45. Jackrel ME, DeSantis ME, Martinez BA, Castellano LM, Stewart RM, Caldwell KA, Caldwell GA, Shorter J (2014) Potentiated Hsp104 variants antagonize diverse proteotoxic misfolding events. Cell 156:170-182. CrossRef Medline
46. Jahn H, Wittke S, Zürbig P, Raedler TJ, Arlt S, Kellmann M, Mullen W, Eichenlaub M, Mischak H, Wiedemann K (2011) Peptide fingerprinting of Alzheimer’s disease in cerebrospinal fluid: identification and prospective evaluation of new synaptic biomarkers. PLoS One 6:e26540. CrossRef Medline
47. Jones DR, Moussaud S, McLean P (2014) Targeting heat shock proteins to modulate alpha-synuclein toxicity. Ther Adv Neurol Disord 7:33-51. CrossRef Medline
48. Kalia LV, Kalia SK, Chau H, Lozano AM, Hyman BT, McLean PJ (2011) Ubiquitinylation of '-synuclein by carboxyl terminus Hsp70-interacting protein (CHIP) is regulated by Bcl-2-associated athanogene 5 (BAG5). PLoS One 6:e14695. CrossRef Medline
49. Karagöz GE, Duarte AM, Akoury E, Ippel H, Biernat J, Morán Luengo T, Radli M, Didenko T, Nordhues BA, Veprintsev DB, Dickey CA, Mandelkow E, Zweckstetter M, Boelens R, Madl T, Rüdiger SG (2014) Hsp90-Tau complex reveals molecular basis for specificity in chaperone action. Cell 156:963-974. CrossRef Medline
50. Kikuchi K, Arawaka S, Koyama S, Kimura H, Ren CH, Wada M, Kawanami T, Kurita K, Daimon M, Kawakatsu S, Kadoya T, Goto K, Kato T (2003) An N-terminal fragment of ProSAAS (a granin-like neuroendocrine peptide precursor) is associated with tau inclusions in Pick’s disease. Biochem Biophys Res Commun 308:646-654. CrossRef Medline
51. Kim YE, Hipp MS, Bracher A, Hayer-Hartl M, Hartl FU (2013) Molecular chaperone functions in protein folding and proteostasis. Annu Rev Biochem 82:323-355. CrossRef Medline
52. King OD, Gitler AD, Shorter J (2012) The tip of the iceberg: RNA-binding proteins with prion-like domains in neurodegenerative disease. Brain Res 1462:61-80. CrossRef Medline
53. Klucken J, Ingelsson M, Shin Y, Irizarry MC, Hedley-Whyte ET, Frosch M, Growdon J, McLean P, Hyman BT (2006) Clinical and biochemical correlates of insoluble alpha-synuclein in dementia with Lewy bodies. Acta Neuropathol 111:101-108. CrossRef Medline
54. Knowles TP, Vendruscolo M, Dobson CM (2014) The amyloid state and its association with protein misfolding diseases. Nat Rev Mol Cell Biol 15: 384-396. CrossRef Medline
55. Kon M, Cuervo AM (2010) Chaperone-mediated autophagy in health and disease. FEBS Lett 584:1399-1404. CrossRef Medline
56. Kudo H, Liu J, Jansen EJ, Ozawa A, Panula P, Martens GJ, Lindberg I (2009) Identification of proSAAS homologs in lower vertebrates: conservation of hydrophobic helices and convertase-inhibiting sequences. Endocrinology 150:1393-1399. CrossRef Medline
57. Lanoue E, Day R (2001) Coexpression of proprotein convertase SPC3 and the neuroendocrine precursor proSAAS. Endocrinology 142:4141-4149. CrossRef Medline
58. Lee SN, Lindberg I (2008) 7B2 prevents unfolding and aggregation of prohormone convertase 2. Endocrinology 149:4116-4127. CrossRef Medline
59. Li T, Lucius AL (2013) Examination of the polypeptide substrate specificity for Escherichia coli ClpA. Biochemistry 52:4941-4954. CrossRef Medline
60. Li X, Masliah E, Reixach N, Buxbaum JN (2011) Neuronal production of transthyretin in human and murine Alzheimer’s disease: is it protective? J Neurosci 31:12483-12490. CrossRef Medline
61. Li X, Zhang X, Ladiwala AR, Du D, Yadav JK, Tessier PM, Wright PE, Kelly JW, Buxbaum JN (2013) Mechanisms of transthyretin inhibition of β-amyloid aggregation in vitro. J Neurosci 33:19423-19433. CrossRef Medline
62. Ling SC, Polymenidou M, Cleveland DW (2013) Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron 79: 416-438. CrossRef Medline
63. Liu J, Zhang JP, Shi M, Quinn T, Bradner J, Beyer R, Chen S, Zhang J (2009) Rab11a and HSP90 regulate recycling of extracellular alpha-synuclein. J Neurosci 29:1480-1485. CrossRef Medline
64. Lo Bianco C, Shorter J, Régulier E, Lashuel H, Iwatsubo T, Lindquist S, Aebischer P (2008) Hsp104 antagonizes alpha-synuclein aggregation and reduces dopaminergic degeneration in a rat model of Parkinson disease. J Clin Invest 118:3087-3097. CrossRef Medline
65. Ma SL, Pastorino L, Zhou XZ, Lu KP (2012a) Prolyl isomerase Pin1 promotes amyloid precursor protein (APP) turnover by inhibiting glycogen synthase kinase-3β(GSK3β) activity: novelmechanismfor Pin1 to protect against Alzheimer disease. J Biol Chem 287:6969-6973. CrossRef Medline
66. Ma SL, Tang NL, Tam CW, Lui VW, Lam LC, Chiu HF, Driver JA, Pastorino L, Lu KP (2012b) A PIN1 polymorphism that prevents its suppression by AP4 associates with delayed onset of Alzheimer’s disease. Neurobiol Aging 33:804-813. CrossRef Medline
67. Mannini B, Mulvihill E, Sgromo C, Cascella R, Khodarahmi R, Ramazzotti M, Dobson CM, Cecchi C, Chiti F (2014) Toxicity of protein oligomers is rationalized by a function combining size and surface hydrophobicity. ACS Chem Biol 9:2309-2317. CrossRef Medline
68. Mbikay M, Seidah NG, Chrétien M (2001) Neuroendocrine secretory protein 7B2: structure, expression and functions. Biochem J 357:329-342. CrossRef Medline
69. McFarland NR, Dimant H, Kibuuka L, Ebrahimi-Fakhari D, Desjardins CA, Danzer KM, Danzer M, Fan Z, Schwarzschild MA, Hirst W, McLean PJ (2014) Chronic treatment with novel small molecule Hsp90 inhibitors rescues striatal dopamine levels but not '-synuclein-induced neuronal cell loss. PLoS One 9:e86048. CrossRef Medline
70. McLean PJ, Kawamata H, Shariff S, Hewett J, Sharma N, Ueda K, Breakefield XO, Hyman BT (2002) TorsinA and heat shock proteins act as molecular chaperones: suppression of alpha-synuclein aggregation. J Neurochem 83:846-854. CrossRef Medline
71. McLean PJ, Klucken J, Shin Y, Hyman BT (2004) Geldanamycin induces Hsp70 and prevents alpha-synuclein aggregation and toxicity in vitro. Biochem Biophys Res Commun 321:665-669. CrossRef Medline
72. Mueller JW, Kessler D, Neumann D, Stratmann T, Papatheodorou P, Hartmann-Fatu C, Bayer P (2006) Characterization of novel elongated Parvulin isoforms that are ubiquitously expressed in human tissues and originate from alternative transcription initiation. BMC Mol Biol 7:9. CrossRef Medline
73. Mzhavia N, Qian Y, Feng Y, Che FY, Devi LA, Fricker LD (2002) Processing of proSAAS in neuroendocrine cell lines. Biochem J 361:67-76. CrossRef Medline
74. Oddo S, Vasilevko V, Caccamo A, Kitazawa M, Cribbs DH, LaFerla FM (2006) Reduction of soluble Abeta and tau, but not soluble Abeta alone, ameliorates cognitive decline in transgenic mice with plaques and tangles. J Biol Chem 281:39413-39423. CrossRef Medline
75. Ojha J, Masilamoni G, Dunlap D, Udoff RA, Cashikar AG (2011) Sequestration of toxic oligomers by HspB1 as a cytoprotective mechanism. Mol Cell Biol 31:3146-3157. CrossRef Medline
76. O’Leary JC 3rd, Li Q, Marinec P, Blair LJ, Congdon EE, Johnson AG, Jinwal UK, Koren J 3rd, Jones JR, Kraft C, Peters M, Abisambra JF, Duff KE, Weeber EJ, Gestwicki JE, Dickey CA (2010) Phenothiazine-mediated rescue of cognition in tau transgenic mice requires neuroprotection and reduced soluble tau burden. Mol Neurodegener 5:45. CrossRef Medline
77. Pasinetti GM, Ungar LH, Lange DJ, Yemul S, Deng H, Yuan X, Brown RH, Cudkowicz ME, Newhall K, Peskind E, Marcus S, Ho L (2006) Identification of potential CSF biomarkers in ALS. Neurology 66:1218-1222. CrossRef Medline
78. Petrucelli L, Dickson D, Kehoe K, Taylor J, Snyder H, Grover A, De Lucia M, McGowan E, Lewis J, Prihar G, Kim J, Dillmann WH, Browne SE, Hall A, Voellmy R, Tsuboi Y, Dawson TM, Wolozin B, Hardy J, Hutton M (2004) CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation. Hum Mol Genet 13:703-714. CrossRef Medline
79. Pickart CM, Cohen RE (2004) Proteasomes and their kin: proteases in the machine age. Nat RevMol Cell Biol 5:177-187. CrossRef Medline
80. Putcha P, Danzer KM, Kranich LR, Scott A, Silinski M, Mabbett S, Hicks CD, Veal JM, Steed PM, Hyman BT, McLean PJ (2010) Brain-permeable small-molecule inhibitors of Hsp90 prevent alpha-synuclein oligomer formation and rescue alpha-synuclein-induced toxicity. J Pharmacol Exp Ther 332:849-857. CrossRef Medline
81. Ryno LM, Wiseman RL, Kelly JW (2013) Targeting unfolded protein response signaling pathways to ameliorate protein misfolding diseases. Curr Opin Chem Biol 17:346-352. CrossRef Medline
82. Santacruz K, Lewis J, Spires T, Paulson J, Kotilinek L, Ingelsson M, Guimaraes A, DeTure M, Ramsden M, McGowan E, Forster C, Yue M, Orne J, Janus C, Mariash A, Kuskowski M, Hyman B, Hutton M, AsheKH (2005) Tau suppression in a neurodegenerative mouse model improves memory function. Science 309:476-481. CrossRef Medline
83. Sayah M, Fortenberry Y, Cameron A, Lindberg I (2001) Tissue distribution and processing of proSAAS by proprotein convertases. J Neurochem 76: 1833-1841. CrossRef Medline
84. Schwarzman AL, Gregori L, Vitek MP, Lyubski S, Strittmatter WJ, Enghilde JJ, Bhasin R, Silverman J, Weisgraber KH, Coyle PK (1994) Transthyretin sequesters amyloid beta protein and prevents amyloid formation. Proc Natl Acad Sci U S A 91:8368-8372. CrossRef Medline
85. Shin Y, Klucken J, Patterson C, Hyman BT, McLean PJ (2005) The cochaperone carboxyl terminus of Hsp70-interacting protein (CHIP) mediates alpha-synuclein degradation decisions between proteasomal and lysosomal pathways. J Biol Chem 280:23727-23734. CrossRef Medline
86. Shorter J (2011) The mammalian disaggregase machinery: Hsp110 synergizes with Hsp70 and Hsp40 to catalyze protein disaggregation and reactivation in a cell-free system. PLoS One 6:e26319. CrossRef Medline
87. Shorter J, Lindquist S (2004) Hsp104 catalyzes formation and elimination of selfreplicating Sup35 prion conformers. Science 304:1793-1797. CrossRef Medline
88. Shoulders MD, Ryno LM, Genereux JC, Moresco JJ, Tu PG, Wu C, Yates JR 3rd, Su AI, Kelly JW, Wiseman RL (2013) Stress-independent activation of XBP1s and/or ATF6 reveals three functionally diverse ER proteostasis environments. Cell Rep 3:1279-1292. CrossRef Medline
89. Spillantini MG, Murrell JR, Goedert M, Farlow MR, Klug A, Ghetti B (1998) Mutation inthetaugenein familialmultiplesystemtauopathywithpreseniledementia. Proc Natl Acad SciUS A95:7737-7741. CrossRef Medline
90. Tetzlaff JE, Putcha P, Outeiro TF, Ivanov A, Berezovska O, Hyman BT, McLean PJ (2008) CHIP targets toxic alpha-synuclein oligomers for degradation. J Biol Chem 283:17962-17968. CrossRef Medline
91. Thuringer D, Jego G, Wettstein G, Terrier O, Cronier L, Yousfi N, Hébrard S, Bouchot A, Hazoumé A, Joly AL, Gleave M, Rosa-Calatrava M, Solary E, Garrido C (2013) Extracellular HSP27 mediates angiogenesis through Toll-like receptor 3. FASEB J 27:4169-4183. CrossRef Medline
92. Torrente MP, Shorter J (2013) The metazoan protein disaggregase and amyloid depolymerase system: Hsp110, Hsp70, Hsp40, and small heat shock proteins. Prion 7:457-463. CrossRef Medline
93. Valastyan JS, Lindquist S (2014) Mechanisms of protein-folding diseases at a glance. Dis Model Mech 7:9-14. CrossRef Medline
94. von Bergen M, Barghorn S, Li L, Marx A, Biernat J, Mandelkow EM, Mandelkow E (2001) Mutations of tau protein in frontotemporal dementia promote aggregation of paired helical filaments by enhancing local betastructure. J Biol Chem 276:48165-48174. Medline
95. Wada M, Ren CH, Koyama S, Arawaka S, Kawakatsu S, Kimura H, Nagasawa H, Kawanami T, Kurita K, Daimon M, Hirano A, Kato T (2004) A human granin-like neuroendocrine peptide precursor (proSAAS) immunoreactivity in tau inclusions of Alzheimer’s disease and parkinsonismdementia complex on Guam. Neurosci Lett 356:49-52. CrossRef Medline
96. Walter P, Ron D (2011) The unfolded protein response: from stress pathway to homeostatic regulation. Science 334:1081-1086. CrossRef Medline
97. Weibezahn J, Schlieker C, Tessarz P, Mogk A, Bukau B (2005) Novel insights into the mechanism of chaperone-assisted protein disaggregation. Biol Chem 386:739-744. CrossRef Medline
98. Winkler J, Tyedmers J, Bukau B, Mogk A (2012) Chaperone networks in protein disaggregation and prion propagation. J Struct Biol 179:152-160. CrossRef Medline
99. Witt SN (2013) Molecular chaperones, alpha-synuclein, and neurodegeneration. Mol Neurobiol 47:552-560. CrossRef Medline
100. Wyatt AR, Yerbury JJ, Dabbs RA, Wilson MR (2012) Roles of extracellular chaperones in amyloidosis. J Mol Biol 421:499-516. CrossRef Medline
101. Wyatt AR, Yerbury JJ, Ecroyd H, Wilson MR (2013) Extracellular chaperones and proteostasis. Annu Rev Biochem 82:295-322. CrossRef Medline
102. Zhou XZ, Kops O, Werner A, Lu PJ, Shen M, Stoller G, Küllertz G, Stark M, Fischer G, Lu KP (2000) Pin1-dependent prolyl isomerization regulates dephosphorylation of Cdc25C and tau proteins. Mol Cell 6:873-883. CrossRef Medline